Vaxcyte: Financial Durability And The Case For Disruption (NASDAQ:PCVX)

The pneumococcal vaccine market has been dominated for years by large companies using conventional conjugate chemistry methods that are effective; however, there exists a biological ceiling known as "carrier suppression" which limits how far traditional conjugate chemistries canI have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My a ...